The global remote patient monitoring system market size was valued at USD 4.4 billion in 2022 and is expected to register a compound annual growth rate (CAGR) of 18.5% over the forecast period. COVID-19 has caused a significant impact on the industry. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker, thus boosting its demand at a global level. Chronic conditions account for 90% of the healthcare costs in the U.S. annually. This can be prevented by timely assistance provided to patients using a remote monitoring system.
It can delay emergency room visits and hospitalizations as the telemedicine app help in digitizing and automating critical tasks, which reduces hospital administrative tasks, thus increasing product usage. The COVID-19 pandemic has led to a shortage of space in hospitals. Apart from this, patients, especially those suffering from chronic diseases, are also advised to avoid physical visits to hospitals owing to the threat of getting infected. This led to the development of the global market. A large number of investments are made by firms by collaborating, acquiring, and partnering with new emerging startups.
The personalized telemedicine app provides a communication platform for remote and real-time monitoring of patients that acts as a bridge between caregiver and patient. This step-change, borne out of necessity, has changed the entire look of the market post-pandemic as well. This change has sped up recovery rates as consumers are more willing to join the app. It has also increased the provider’s willingness to use the app, and it offers greater access and reimbursements. According to the Centers for Disease Control and Prevention (CDC), over 100 million people have hypertension in the U.S.
Hypertension further increases the risk of heart disease. The American Heart Association (AHA) also supports initiatives that increase access to the use of remote patient monitoring (RPM) technologies for better health management. Efforts from device manufacturers to develop advanced products are expected to further propel the growth. For instance, in July 2021, Philips and BioIntelliSense formed a strategic collaboration to enhance RPM solutions. Philips integrated the latter’s BioSticker device into its RPM portfolio. It is a wearable device that monitors chronic conditions and keeps a track of COVID-19 symptoms as well.
Based on products, the industry is segmented into vital sign monitors and special monitors. The special monitors segment led the industry in 2022 and accounted for the largest share of more than 82.75% of the overall revenue due to its ability to monitor clinically important data pre-and post-surgery, identify symptoms, and prevent complications. Advanced features, such as wireless communication and iPad connectivity, allow early diagnosis and higher applicability of the products. Vital sign monitors can effectively track a patient’s ECG, noninvasive blood pressure, body temperature, respiration rate, and brain activity.
Integration of more than one vital sign monitor in a single system is expected to boost the popularity of these products thereby leading to increased adoption during the forecast period. The vital sign monitors segment is expected to witness the fastest growth rate over the forecast period. Heart rate monitor is a dominating product sub-segment due to the increasing incidence of cardiac conditions globally. Arise in the number of individuals with heart disorders has led to the increased usage of these monitors. In 2019, Withings introduced the most advanced and diverse home cardiovascular monitors at CES. It is expected to be the first product that measures BP and records ECG & heart readings via digital stethoscope in one device
On the basis of applications, the market is segmented into cancer, cardiovascular diseases, diabetes, sleep disorder, weight management and fitness monitoring, bronchitis, infections, virus, dehydration, and hypertension. Diabetes emerged as the leading application segment in 2022 and accounted for over 13.00% of the overall revenue share. Diabetes is one of the leading causes of death, which requires continuous monitoring of blood glucose levels. It is known to affect various functions of the body including heart activity, vision, liver function, and renal activity.
Hence, continuous and routine monitoring is required, which can be easily accomplished using RPM devices. The hypertension application segment is also expected to witness significant growth over the forecast period. Hypertension increases the risk of cardiovascular diseases. According to the World Health Organization (WHO), worldwide, over 1 billion people have hypertension. Remote patient monitoring can play a key role in controlling hypertension. The cardiovascular disease treatment segment is expected to witness a lucrative growth rate over the forecast period due to the increasing prevalence of the disease.
The hospital end-use segment led the industry in 2022 and accounted for the maximum share of 80.00% of the overall revenue share. Hospitals cater to a large number of outpatients as well as inpatients. They offer a large number of diagnostic tests and have a larger technical staff for catering to the needs of the patients. A large patient pool and an increasing number of tests being performed are vital drivers for segment growth. However, alternate site monitoring, especially home healthcare, is anticipated to exhibit a sturdy CAGR over the forecast period.
The cost-efficiency of this alternate site along with the availability of qualified resources is expected to support the growth. In addition, considering the increasing strain on hospital resources and personnel, RPM presents market players with huge opportunities in terms of partnering with hospitals & other healthcare settings and launching new products to facilitate affordable care at a patient’s home. In addition, the pandemic has increased the number of patients interacting with their doctors from home, boosting the product.
North America dominated the global industry in 2022 and accounted for the largest share of more than 41.45% of the overall revenue. An increase in the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structures, aimed at cutting out-of-pocket expenditure, are the major factors attributed to the regional market growth. Europe, especially the Western European countries, is expected to remain the second-largest revenue-generating region over the forecast period.
This can be attributed to the higher mortality rate and rising demand for low-cost treatment. Rising demand for in-house monitoring, supportive central data management systems and rising accuracy & efficiency of RPM are the high-impact rendering drivers for the region’s growth. Asia Pacific is expected to witness the fastest CAGR over the forecast period owing to the presence of untapped opportunities in the emerging markets of India and China. Japan is expected to be a key revenue generator owing to its high geriatric population.
The major trend in the market is the enhancement of existing technologies, new product launches, product portfolio expansion, and mergers or tie-ups with healthcare facilities. In February 2021, Philips acquired BioTelemetry, Inc. This acquisition is expected to aid Philips to increase its patient monitoring portfolio by adding BioTelemetry’s cardiac diagnostics and monitoring devices. Expanding manufacturing operations to countries with high population and disease burdens is also a strategy currently undertaken by players. In June 2020, Mindray announced the expansion of its new R&D facility in China. This facility will become a distinctive R&D, manufacturing, and operation center of medical equipment systems. Some of the prominent key players in the global remote patient monitoring system market include:
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Nihon Kohden Corp.
OSI Systems, Inc.
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
Boston Scientific Corp.
Johnson & Johnson
Market size value in 2023
USD 5.2 billion
Revenue forecast in 2030
USD 16.9 billion
CAGR of 18.5% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Sweden; Denmark; Norway; China; Japan; India; Thailand; South Korea; Australia; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Honeywell; American Telecare; Roche; Philips Healthcare; Bosch; Biotronik; Intel; Welch Allyn; Health anywhere Inc.; Johnson & Johnson; Covidien Plc.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth on global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global remote patient monitoring system market report on the basis of product, application, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Vital Sign Monitors
Blood Pressure Monitors
Heart Rate Monitor (ECG)
Respiratory Rate Monitor
Brain Monitoring (EEG)
Blood Glucose Monitors
Cardiac Rhythm Monitor
Fetal Heart Monitors
Multi Parameter Monitors (MPM)
Application Outlook (Revenue, USD Million, 2018 - 2030)
Weight management and Fitness Monitoring
End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
b. The global remote patient monitoring system market size was estimated at USD 4.4 billion in 2022 and is expected to reach USD 5.2 billion in 2023
b. The global remote patient monitoring system market is expected to grow at a compound annual growth rate of 18.5% from 2023 to 2030 to reach USD 16.9 billion by 2030.
b. North America dominated the remote patient monitoring system market with a share of 41.5% in 2022. This is attributable to the increasing geriatric population, the incidence of chronic diseases, demand for wireless and portable systems coupled with the presence of a sophisticated reimbursement structure aimed at cutting out-of-pocket expenditure levels.
b. Some key players operating in the remote patient monitoring system market include Honeywell; American Telecare; Roche; Philips Healthcare; Bosch; Biotronik; Intel; Welch Allyn; Health anywhere Inc.; Johnson & Johnson; and Covidien Plc.
b. Key factors that are driving the RPM system market growth include the growing geriatric population and their rising demand for a better lifestyle along with quality care and cost-effective treatment.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
"The quality of research they have done for us has been excellent."